NYSE - Nasdaq Real Time Price USD

Cencora, Inc. (COR)

Compare

Time to buy COR?

283.68

-0.76

(-0.27%)

As of 9:53:09 AM EDT. Market Open.

Time to buy COR?

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks 3 days ago

COR
-0.27%
Sellers Rule The Roost Amid Tariff Wars, But This Stock Hits A High

Growth stocks are taking a beating as markets tumble amid mounting trade wars. One such stock is Cencora. Cencora is holding up near an all-time high as indexes crash amid escalating U.S.-China trade tensions.

Investor's Business Daily 12 days ago

COR
-0.27%
AWK
Insiders At Cencora Sold US$16m In Stock, Alluding To Potential Weakness

The fact that multiple Cencora, Inc. ( NYSE:COR ) insiders offloaded a considerable amount of shares over the past year...

Simply Wall St. 15 days ago

COR
-0.27%
Cencora Announces Date and Time for Second Quarter Fiscal 2025 Earnings Release

CONSHOHOCKEN, Pa., March 28, 2025--Cencora, Inc. (NYSE: COR) today announced that it plans to release its results for the Second Quarter of Fiscal 2025 on Wednesday, May 7, 2025, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m. ET on May 7, 2025.

Business Wire 20 days ago

COR
-0.27%
Cencora (COR) is a Top-Ranked Value Stock: Should You Buy?

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks 21 days ago

COR
-0.27%
Cencora, Inc. (COR) Hit a 52 Week High, Can the Run Continue?

Cencora (COR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Zacks 21 days ago

COR
-0.27%
Here is Why Growth Investors Should Buy Cencora (COR) Now

Cencora (COR) possesses solid growth attributes, which could help it handily outperform the market.

Zacks 29 days ago

COR
-0.27%
This Medical Services Stock Looks Relatively Healthy In A Sick Market

This medical supplies distributor raised its 2025 earnings outlook on Monday. Cencora stock is near a buy point of a newly formed base.

Investor's Business Daily last month

COR
-0.27%
Here's Why Cencora (COR) is a Strong Growth Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks last month

COR
-0.27%
Cencora (NYSE:COR) Eyes Acquisitions and Technology Investments with Potential OneOncology Buyout

Cencora (NYSE:COR) has made headlines with its announcement on March 10, 2025, detailing plans for strategic acquisitions and investments in technology infrastructure, aiming to drive future growth. Over the last quarter, the company's share price increased by 10%, a move potentially influenced by these forward-looking strategies. During this period, despite challenging market conditions with the broader market dropping 5%, Cencora's focus on acquisitions and investments may have bolstered...

Simply Wall St. last month

COR
-0.27%
Here's Why Cencora (COR) is a Strong Value Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks last month

COR
-0.27%
Cencora, Inc. (COR) Hits Fresh High: Is There Still Room to Run?

Cencora (COR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Zacks last month

MD

COR
-0.27%
These 4 Measures Indicate That Cencora (NYSE:COR) Is Using Debt Reasonably Well

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

Simply Wall St. last month

COR
-0.27%
3 Reasons Why Growth Investors Shouldn't Overlook Cencora (COR)

Cencora (COR) possesses solid growth attributes, which could help it handily outperform the market.

Zacks last month

COR
-0.27%
Why Cencora (COR) is a Top Growth Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks last month

COR
-0.27%
Investors in Cencora (NYSE:COR) have seen splendid returns of 172% over the past five years

When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose...

Simply Wall St. last month

COR
-0.27%
The Magnificent 7 Are So Last Year. Cash Cows Are the New Kings.

A twist on value has investors waking up to the beauty of companies returning gobs of cash to shareholders.

The Wall Street Journal 2 months ago

CALF

COR
-0.27%
AAPL
Possible Bearish Signals With Cencora Insiders Disposing Stock

Over the past year, many Cencora, Inc. ( NYSE:COR ) insiders sold a significant stake in the company which may have...

Simply Wall St. 2 months ago

COR
-0.27%
Cencora Announces Common Share Repurchase From Walgreens Boots Alliance

CONSHOHOCKEN, Pa., February 07, 2025--Cencora, Inc. (NYSE: COR) today announced that it has agreed to repurchase shares of its common stock from Walgreens Boots Alliance Holdings LLC in the amount of approximately $50 million in concurrence with Walgreens Boots Alliance’s sale of Cencora shares pursuant to Rule 144 under the Securities Act of 1933, as amended.

Business Wire 2 months ago

COR
-0.27%
Market Chatter: McKesson, AmerisourceBergen's Joint Motion to Dismiss Antitrust Case Granted by Pennsylvania Judge

McKesson (MCK) and AmerisourceBergen's (ABC) joint motion to dismiss an antitrust case filed by rese

PREMIUM
MT Newswires 2 months ago

MCK

COR
-0.27%

Performance Overview

Return	COR	S&P 500 (^GSPC)
YTD	+26.54%	-9.82%
1-Year	+19.95%	+5.61%
3-Year	+81.59%	+20.74%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Cencora, Inc. (COR)

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio

Sellers Rule The Roost Amid Tariff Wars, But This Stock Hits A High

Insiders At Cencora Sold US$16m In Stock, Alluding To Potential Weakness

Cencora Announces Date and Time for Second Quarter Fiscal 2025 Earnings Release

Cencora (COR) is a Top-Ranked Value Stock: Should You Buy?

Cencora, Inc. (COR) Hit a 52 Week High, Can the Run Continue?

Here is Why Growth Investors Should Buy Cencora (COR) Now

This Medical Services Stock Looks Relatively Healthy In A Sick Market

Here's Why Cencora (COR) is a Strong Growth Stock

Cencora (NYSE:COR) Eyes Acquisitions and Technology Investments with Potential OneOncology Buyout

Here's Why Cencora (COR) is a Strong Value Stock

Cencora, Inc. (COR) Hits Fresh High: Is There Still Room to Run?

These 4 Measures Indicate That Cencora (NYSE:COR) Is Using Debt Reasonably Well

3 Reasons Why Growth Investors Shouldn't Overlook Cencora (COR)

Why Cencora (COR) is a Top Growth Stock for the Long-Term

Investors in Cencora (NYSE:COR) have seen splendid returns of 172% over the past five years

The Magnificent 7 Are So Last Year. Cash Cows Are the New Kings.

Possible Bearish Signals With Cencora Insiders Disposing Stock

Cencora Announces Common Share Repurchase From Walgreens Boots Alliance

Market Chatter: McKesson, AmerisourceBergen's Joint Motion to Dismiss Antitrust Case Granted by Pennsylvania Judge

Performance Overview